Broach Lifecare Hospital Ltd vs Indraprastha Medical Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Broach Lifecare Hospital Ltd is ₹ 12.7 as of 27 Oct 15:30 . The P/E Ratio of Broach Lifecare Hospital Ltd changed from 18.8 on March 2025 to 124.2 on March 2026 . This represents a CAGR of 157.03% over 2 yearsThe P/E Ratio of Indraprastha Medical Corporation Ltd changed from 215 on March 2021 to 18.5 on March 2026 . This represents a CAGR of -33.56% over 6 years The Market Cap of Broach Lifecare Hospital Ltd changed from ₹ 10.04 crore on March 2025 to ₹ 10.56 crore on March 2026 . This represents a CAGR of 2.56% over 2 yearsThe Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 492.74 crore on March 2021 to ₹ 3407 crore on March 2026 . This represents a CAGR of 38.03% over 6 years The revenue of Broach Lifecare Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 421.4 crore as compare to the Jun '26 revenue of ₹ 414.57 crore. This represent the growth of 1.65% The ebitda of Broach Lifecare Hospital Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 85.99 crore as compare to the Jun '26 ebitda of ₹ 88.23 crore. This represent the decline of -2.54% The net profit of Broach Lifecare Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 53.58 crore over 10 quarters. This represents a CAGR of 7.45% The Dividend Payout of Broach Lifecare Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 years .

About Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Limited was incorporated as 'Broach Lifecare Hospital Private Limited' dated April 25, 2023, with the Registrar of Companies, Central Registration Centre.
Further, in accordance with the main objects, the Company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, the Promoter comprising of the Hospitals i.e.
Dr. Vyas's Heart Hospital and Dr. Vyas Hospital pursuant to a Business Transfer Agreement date July 17, 2023.
Thereafter, the Company was converted into a public limited Company and the name was changed to Broach Lifecare Hospital Limited' dated November 7, 2023 at ROC, Ahmedabad. The Company operates boutique Hospitals under the brand 'Maple Hospitals' and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography in June 2023, the Company ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (PCI) and primary PCI for acute myocardial infarction as a division.

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

FAQs for the comparison of Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd

Which company has a larger market capitalization, Broach Lifecare Hospital Ltd or Indraprastha Medical Corporation Ltd?

Market cap of Broach Lifecare Hospital Ltd is 7 Cr while Market cap of Indraprastha Medical Corporation Ltd is 2,797 Cr

What are the key factors driving the stock performance of Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd?

The stock performance of Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd?

As of November 1, 2026, the Broach Lifecare Hospital Ltd stock price is INR ₹12.7. On the other hand, Indraprastha Medical Corporation Ltd stock price is INR ₹305.15.

How do dividend payouts of Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd compare?

To compare the dividend payouts of Broach Lifecare Hospital Ltd and Indraprastha Medical Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.